Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Muscle relaxants and anesthetic drugs for preventing intracranial pressure rise during endotracheal suctioning in craniocerebral trauma
ChiCTR1800014680Phase 4Recruiting
- Sponsor
- The Second Affiliated Hospital of Dalian Medical University
- Start
- Jan 2018
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of remifentanil, propofol and cisatracurium in intracranial hypertension (IH), sponsored by The Second Affiliated Hospital of Dalian Medical University. Primary endpoints: intracranial pressure and cough reflex grading. Started Jan 2018; status: recruiting.
02
Drugs
remifentanilpropofolcisatracurium
03
Conditions
intracranial hypertension (IH)
Beyond the preview
Go deeper on ChiCTR1800014680.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800014680.